Guidant seeks FDA approval for intravascular radiotherapy system

AuntMinnie.com staff writers

Dec 21, 2000

Indianapolis-based Guidant filed earlier this week for U.S. FDA approval of an intravascular radiotherapy system. The product, named Galileo, is currently available in Europe and is designed to prevent the recurrence of blockages in coronary arteries.

Galileo is an automated component system that uses a centering catheter to reach the treatment area. A source delivery unit then advances a wire containing the radioisotope to the diseased coronary artery. The product received CE Mark approval in May 2000.

By AuntMinnie.com staff writers
December 22, 2000
Related Reading

Guidant begins cerebrovascular stenting trial, November 13, 2000

Guidant stent for large arteries cleared for market, September 11, 2000

Guidant launches peripheral stent trial, August 30, 2000

Boston Scientific, Guidant bury hatchet, May 17, 2000

Copyright © 2000 AuntMinnie.com

Minimally invasive spine surgeries reduce long-term opioid use

December 13, 2024

RFA successful for treating malignant thyroid nodules

December 13, 2024

Ultrasound-guided nerve blocks safe for emergency pain management

November 13, 2024

Thermal ablation effective long term in patients with thyroid cancer

November 7, 2024

Minimally invasive spine surgeries reduce long-term opioid use

Minimally invasive image-guided procedures to treat osteoporotic vertebral fractures appear to be effective for decreasing long-term use of pain medication.

December 13, 2024

RFA successful for treating malignant thyroid nodules

By Amerigo Allegretto

Radiofrequency ablation (RFA) can successfully treat malignant thyroid nodules with minimal adverse events.

December 13, 2024

Ultrasound-guided nerve blocks safe for emergency pain management

By Amerigo Allegretto

Ultrasound-guided nerve blocks (UGNBs) performed by emergency clinicians could be safe for pain management.

November 13, 2024

Thermal ablation effective long term in patients with thyroid cancer

Outcomes over 10 years suggest that image-guided thermal ablation is a safe and effective option for patients with papillary thyroid carcinoma.

November 7, 2024

Mass. radiology provider may be liable for 'unavailable' IR physician

By Kate Madden Yee

The Massachusetts Court of Appeals has ruled that a radiology services provider could be held liable for failing to provide a patient with access to an on-call interventional radiologist.

October 28, 2024

Lawsuit 6511c4190f4c2

GAE could be cost-effective for knee osteoarthritis

Genicular artery embolization (GAE) is likely a cost-effective treatment for symptomatic knee osteoarthritis.

September 26, 2024

PAE mitigates enlarged prostate symptoms after 2 years

Men with enlarged prostates who undergo minimally invasive prostatic artery embolization (PAE) have significant improvements in symptoms after two years.

September 5, 2024

Prostate Imaging

Acute stroke intervention results in long-term benefits

The benefits of endovascular thrombectomy in patients with acute basilar artery occlusion are sustained at long-term follow-up.

August 26, 2024

Should there be an age limit for performing EVT in stroke patients?

Could a fixed upper age limit be justified for performing endovascular thrombectomies (EVT) to treat the oldest elderly stroke patients?

August 12, 2024

Cryoneurolysis effective for pain control after rib fractures

CT-guided cryoneurolysis – the freezing of nerves to alleviate pain – is safe and effective in older adults with rib fractures.

August 7, 2024

Cryoablation safe, effective in treating soft-tissue sarcoma

By Amerigo Allegretto

Percutaneous cryoablation is safe and effective for patients with recurrent or metastatic soft-tissue sarcoma after earlier treatments.

August 1, 2024

(A) Axial noncontrast CT chest image shows soft tissue mass in the anterior chest wall (arrow). The lesion was treated by percutaneous cryoablation. (B) Intraprocedural axial CT image obtained during cryoablation. The pink outline represents the target lesion and the blue outline represents ice ball. Based on review, the procedure was classified as achieving adequate ablation. (C) Axial contrast-enhanced CT chest image, obtained three months after ablation (patient’s first follow-up exam), shows involution of the target lesion without evidence of residue. Image courtesy of the ARRS.

A few interventional radiologists get lion's share of industry payments

By Erik L. Ridley

A very small percentage of interventional radiologists are benefitting the most from industry payments.

July 24, 2024

Page 1 of 181